LIVE POLIO IRUS VACCINES

Index
609
Attack rates-continued
high in unvaccinated in US, 575
in Salk and non-Salk vaccinees, 480
in unvaccinated and vaccinated, 573
Mauritius, 476
Mexican cities, 386
Nicaragua, 1958, 1959, 547, 553, 575
Attenuated live poliovirus vaccine, see Vaccine, Attenuated
Attenuation
correlation with elution pattern, 44
neurovirulence for monkeys, most acceptable measure,
37
process described, 61
Sabin, Lederle-Cox strains compared, 12
Aureomycin to prevent enteritis, 68
Avidity
differences in antibodies, 235
of antibodies during early stages of polio, 228
of nerve cells for attenuated vaccine, 49
of virus by the DEAE column, 42
role in immunity, 238
Axis cylinders
paralysis and invasion of muscle neurons, 28
Azerbaijan SSR
two programs, 1960, 419, 582
B virus
destroyed by chloroform and ether, 87
destroyed by photodynamic action of dyes, 87
Babushkin, USSR, serum specimens, 242
Bacterial enterotoxins, destruction of polio, 300
Bacteriophage
occurrence of covariation, 49
T7 burst size increased, conditions needed, 62
Balashikha, USSR, 242
Balkhash, USSR, examinations, 242
Baltic republics, see also specific country: Estonian
SSR, Latvian SSR, Lithuanian SSR
laboratory diagnosis substantiated, 420, 584
mass immunization, 1959, 576
Bard-Parker blade, ear-lobe puncture, 352
Barnes, J., paper 377-385; 101
Baron, Samuel, paper 90-97, 124-131; 86-88, 122-123,
132-133, 269
Barr, Robert N., paper 161-173, 341-354, 357-364;
226, 437, 459
Bauer, Henry, paper 161-173, 341-354, 357-364; 226,
371, 372
Bearman, Jacob E., paper 341-354, 357-364
Belgian Congo, see Congo
Belgium
protection rate of 98.2%, 532
Bell, Joseph A., 202, 506
Bellevue Hospital, N.Y.C., 315
Benyesh-Melnick, Matilda, paper, 12-26
Berman, Peter H., paper, 315-321
Beta-propiolactone inactivated vaccine
conversion rate 98.6% in France, 532
Bias, in clinical interpretation, 344
Bicarbonate content
effect on plaque formation, 188
Bicarbonate marker, see d marker
Biologic systems
describe relationships rather than absolute values,
480
descriptive grading system, advantages, 92
Biphasic process
heterotypic antibodies had character of, 235
Birth-weight
no relation to duration of virus excretion, 288
Black, F. L., 238
Blacksburg strain
Newcastle disease vaccine, 327
Blind children
dissemination and touch communication, 187-188
"Blind immunization"
expectation very low, 505
Blood samples
blood-soaked filter-paper, 351-352
collection and processing, 114, 145, 199, 208, 216,
229, 240, 270, 302, 331, 335, 359, 365, 439,
446, 464, 487, 523, 535, 554, 566, 569
for viremia studies, 351, 358, 362
whole laked blood, 364
Blood typing markers, compared, 458
Bodian, David, 49, 94, 98, 100, 109, 122, 133, 143,
157-158, 205-206, 329, 373-374, 457-459, 462,
505, 594, 596
Boiki, V. M., paper, 413-428
Booster
age six months, 225
and initial feeding, 214
antibody rise and, 257
defined, 373
diseased children, 368
effect of increasing antibody concentration, 336
fourfold inereases or greater, 371
of second dose, 116
polyvalent vaccine, 483
presence of vaccine in community, 161
St. Joseph's Abbey, Worcester, Mass., study, 333
Salk status and, 302, 347
standards for measurement, 602
time for and immunologic response to, 207
Booth Memorial Hospital, St. Paul, Minnesota, 207
Borman, Gerald, paper 90-97, 124-131
Bottiger, Margareta, 188
Bovine amniotic fluid
stool sample diluent, 536
Bovine serum marker
strain tracer in population, 47
Boystown, Nebraska,
Cuban equivalent, 366
Bozeman, S. R., 430
Brain, invasion, described, 39
Breast feeding
no effect on vaccination, 324, 325
British Medical Journal, 205
Bronchopneumonia
fatality in 9-month vaccinee, 197
Brunhilde see Poliomyelitis virus, Type 1, Brunhilde
Brunner, K. T., 228
Buch, I., 530
Bulgaria
vaccine supplied by USSR, 419, 582